Notably, the use of viral vectors may elicit an immune response from the host, resulting in rejection of the vector or edited cells, particularly with repeated administration.[123] Hence, developing a more effective and safer vector for gene editing and GSDM protein regulation in tumor cells is crucial. The gene discussed is GSDMA; the disease is neoplasm.